Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a ...
"Atrial fibrillation and heart failure are growing epidemics, and both beget each other." ---- Jonathan Hsu, MD, MAS, University of California San Diego “Atrial fibrillation and heart failure are ...
CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...
Please provide your email address to receive an email when new articles are posted on . “Cryoconvergent” hybrid ablation for atrial fibrillation may significantly reduce risk for recurrent AF and AF ...
London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...
Please provide your email address to receive an email when new articles are posted on . Patients with atrial fibrillation who lost at least 3% of body weight before catheter ablation were more likely ...
London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...
If medications and lifestyle changes are still not improving your atrial fibrillation symptoms, it may be time to consider a surgical option. Cardiovascular surgeon Jared Bunch, MD, discusses cardiac ...
Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...
Dr. Michael J. Hushion, an electrophysiology specialist at Prairie Cardiovascular in O’Fallon, Ill., is helping bring new hope to patients living with Atrial Fibrillation (AFib), ...
Atrial fibrillation (AF or AFib) is the most common type of heart arrhythmia, affecting millions of people worldwide. Researchers have now developed a new procedure that shows great promise as a safe, ...
We demonstrated a significant rise in CRP at a median of 49 days after AF ablation. Although the subsequent decline in CRP observed at second follow-up (a median of 179 days after ablation) was not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results